Clinical Trial Update: Feasibility of Individualized Therapy for Recurrent Glioblastoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing the feasibility of individualized therapy for glioblastoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: Jennifer Clarke | Conditions: Recurrent Glioblastoma | Phase 1 | Status: COMPLETED